Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Books | Central Library General Section | 615.19 MAN (Browse shelf(Opens below)) | Available | 019930 |
615.19 KER Drug-like properties: concepts, structure design and methods: from ADME to toxicity optimization | 615.19 KUM Biological and pharmaceutical nanomaterials | 615.19 KUM Green and sustainable pharmacy | 615.19 MAN Pharmaceutical industry : | 615.19 MCN characterization of nanoparticles intended for drug delivery | 615.19 PAT Medicinal chemistry / | 615.19 PAT An introduction to medicinal chemistry :\ |
Includes bibliographical references index.
Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA`s authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.
There are no comments on this title.